1/16
11:51 am
eras
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]
Neutral
Report
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike [Yahoo! Finance]
1/16
08:03 am
eras
Erasca (NASDAQ:ERAS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Erasca (NASDAQ:ERAS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/15
04:41 pm
eras
Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference [Yahoo! Finance]
Low
Report
Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference [Yahoo! Finance]
1/15
03:27 pm
eras
Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% [Yahoo! Finance]
Low
Report
Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% [Yahoo! Finance]
1/15
08:31 am
eras
Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]
High
Report
Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]
1/15
05:26 am
eras
Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike [Yahoo! Finance]
High
Report
Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike [Yahoo! Finance]
1/14
10:52 am
eras
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Medium
Report
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
1/13
03:26 pm
eras
Erasca Insider Sells $671K as Stock Jumps 189% This Past Year [Yahoo! Finance]
Medium
Report
Erasca Insider Sells $671K as Stock Jumps 189% This Past Year [Yahoo! Finance]
1/13
08:03 am
eras
Erasca (NASDAQ:ERAS) had its price target raised by analysts at HC Wainwright from $6.00 to $11.00. They now have a "buy" rating on the stock.
High
Report
Erasca (NASDAQ:ERAS) had its price target raised by analysts at HC Wainwright from $6.00 to $11.00. They now have a "buy" rating on the stock.
1/12
06:07 pm
eras
Erasca (NASDAQ:ERAS) was given a new $10.00 price target on by analysts at Stifel Nicolaus.
High
Report
Erasca (NASDAQ:ERAS) was given a new $10.00 price target on by analysts at Stifel Nicolaus.
1/12
08:00 am
eras
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones
Medium
Report
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones
1/9
06:10 am
eras
Erasca (NASDAQ:ERAS) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
High
Report
Erasca (NASDAQ:ERAS) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
1/8
09:02 am
eras
Erasca (NASDAQ:ERAS) was given a new $4.00 price target on by analysts at Morgan Stanley.
High
Report
Erasca (NASDAQ:ERAS) was given a new $4.00 price target on by analysts at Morgan Stanley.
1/7
06:05 am
eras
Erasca (NASDAQ:ERAS) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
High
Report
Erasca (NASDAQ:ERAS) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/6
08:00 am
eras
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/25
07:47 pm
eras
Erasca (ERAS) Valuation Check After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
Low
Report
Erasca (ERAS) Valuation Check After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
12/11
10:17 am
eras
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Low
Report
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
12/9
09:09 am
eras
Erasca (NASDAQ:ERAS) was given a new $5.00 price target on by analysts at Mizuho.
Low
Report
Erasca (NASDAQ:ERAS) was given a new $5.00 price target on by analysts at Mizuho.
11/29
01:34 am
eras
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results [Yahoo! Finance]
Medium
Report
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results [Yahoo! Finance]
11/25
10:17 am
eras
Erasca to Present at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Erasca to Present at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/25
09:08 am
eras
Erasca to Present at the 8th Annual Evercore Healthcare Conference
Medium
Report
Erasca to Present at the 8th Annual Evercore Healthcare Conference
11/14
09:42 am
eras
Erasca (NASDAQ:ERAS) had its price target raised by analysts at Guggenheim from $3.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Erasca (NASDAQ:ERAS) had its price target raised by analysts at Guggenheim from $3.00 to $5.00. They now have a "buy" rating on the stock.
11/13
09:24 am
eras
Erasca GAAP EPS of -$0.11 in-line [Seeking Alpha]
Medium
Report
Erasca GAAP EPS of -$0.11 in-line [Seeking Alpha]
11/12
04:27 pm
eras
Erasca Reports Third Quarter 2025 Business Updates and Financial Results [Yahoo! Finance]
Medium
Report
Erasca Reports Third Quarter 2025 Business Updates and Financial Results [Yahoo! Finance]
11/12
04:01 pm
eras
Erasca Reports Third Quarter 2025 Business Updates and Financial Results
Medium
Report
Erasca Reports Third Quarter 2025 Business Updates and Financial Results